Vamstar Secures $9.5M Series A Funding for AI Platform
Vamstar, a London, UK-based provider of an innovative AI-enabled procurement platform specifically designed for medical supplies and pharmaceuticals, has successfully raised $9.5M in Series A funding. This funding round was led by Alpha Intelligence Capital and Dutch Founders Fund, showcasing a robust interest in the company's vision and model. Additional participation from investors such as btov Partners and Antler further emphasizes the growing support for Vamstar's strategic goals. With this significant influx of capital, Vamstar plans to expedite its market presence and product development initiatives, with a particular focus on leveraging Artificial Intelligence (AI) to enhance its platform for consumables and generics. This will not only improve data quality but also facilitate faster e-commerce capabilities and digitize procurement and sourcing processes for stakeholders throughout the industry.
Founded in 2019 by an innovative trio consisting of Praful Mehta, Richard Freeman, Ph.
.D., and Vishesh Duggar, Vamstar stands out as a cloud-based AI-enabled global B2B healthcare supply chain platform. The company's primary goal is to create seamless electronic connections between buyers and suppliers, thereby automating transaction processes and workflows across the supply chain on an international scale. This platform is instrumental in bridging the gap between various stakeholders in the healthcare system, including suppliers of pharmaceuticals, consumables, medical devices, and digital technology, and public and private buyers such as hospitals, laboratories, health insurance firms, clinics, corporations, universities, and Group Purchasing Organizations (GPOs).
With Vamstar's unique capabilities, buyers can harness the power of Machine Learning to explore diverse suppliers and their extensive catalogs. They can efficiently initiate tenders and sourcing events via automated workflows, receive prioritized bids and quotes, and execute orders electronically, enhancing the source-to-pay (S2P) processes. On the flip side, suppliers benefit from prioritized access to tenders, RFXs, and direct orders from a vast network of 86,000 hospitals and clinics across more than 100 countries. By integrating Vamstar’s platform with their Customer Relationship Management (CRM) and Enterprise Resource Planning (ERP) systems, suppliers can also leverage Machine Learning forecasts and Natural Language Processing (NLP) enriched catalog and tender award data, ultimately leading to a more streamlined order-to-cash (O2C) process.
They've invested in Vamstar
Get to know these Healthtech investors
| Investors | Investment Focus | Startup Investments | Round Size | Connect |
|---|---|---|---|---|
 Alpha Intelligence Capital( ) | ||||
 btov Partners( ) | ||||
 Antler( ) | ||||
| All investors | All investor sectors | All funded startups | All funding rounds |
Click here for a full list of 7,589+ startup investors in the UK